Patrick G Lepore's Net Worth

$14.9 Million

Estimate Recalculated Apr 3, 2024 04:14PM EST

Who is Patrick G Lepore?

Patrick G Lepore has an estimated net worth of $14.9 Million. This is based on reported shares across multiple companies, which include PharMerica CORP, Innoviva, Inc., Matinas BioPharma Holdings, Inc., VYNE Therapeutics Inc., LANNETT CO INC, PAR PHARMACEUTICAL COMPANIES, INC., and Vyteris Holdings (Nevada), Inc..

SEC CIK

Patrick G Lepore's CIK is 0001055404

Past Insider Trading and Trends

2019 was Patrick G Lepore's most active year for acquiring shares with 8 total transactions. Patrick G Lepore's most active month to acquire stocks was the month of December. 2011 was Patrick G Lepore's most active year for disposing of shares, totalling 29 transactions. Patrick G Lepore's most active month to dispose stocks was the month of April. 2007 saw Patrick G Lepore paying a total of $2,950,800.00 for 263,800 shares, this is the most they've acquired in one year. In 2012 Patrick G Lepore cashed out on 668,678 shares for a total of $25,828,742.88, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PharMerica CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-29.57K
$29.25
-$864,922.50
0
Dec 7
Form 4
+19.46%
4.82K
—
—
29.57K
Jun 14
Form 4
+26.38%
5.17K
—
—
24.75K
Jun 17
Form 4
+23.52%
3.73K
—
—
19.59K
Jun 19
Form 4
+37.21%
4.3K
—
—
15.86K
Jun 17
Form 4/A
+92.60%
5.56K
—
—
11.56K
Jun 18
Form 4
+94.75%
5.68K
—
—
11.69K
Jun 17
Form 4
∞
6K
—
—
6K
Jan 14
Form 3
—
0
—
—
0
No matching records found

Innoviva, Inc. (INVA) Snapshot price: $15.575

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+51.68%
19.86K
—
—
58.28K
Apr 20
Form 4
∞
38.42K
—
—
38.42K
Oct 26
Form 3
—
0
—
—
0
No matching records found

Matinas BioPharma Holdings, Inc. (MTNB) Snapshot price: $0.2072

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 2
Form 4
+33.33%
100K
$0.73
$73,050.00
400K
May 14
Form 4
+50.00%
100K
$1.06
$105,530.00
300K
Nov 15
Form 4
—
0
—
—
0
Nov 1
Form 4
+100.00%
100K
$0.72
$71,850.00
200K
Aug 16
Form 4
∞
100K
$0.95
$95,250.00
100K
May 16
Form 4
—
0
—
—
0
Nov 1
Form 4
—
0
—
—
0
Sep 5
Form 3
—
0
—
—
0
No matching records found

VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Dec 13
Form 4
+55.39%
13K
$3.91
$50,778.00
36.47K
Nov 15
Form 4
+576.04%
20K
$2.48
$49,680.00
23.47K
Mar 20
Form 4
—
0
—
—
0
Aug 10
Form 3
—
0
—
—
0
No matching records found

LANNETT CO INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.53%
100K
$0.49
$49,000.00
587.14K
Nov 10
Form 4
+11.44%
50K
$0.54
$27,000.00
487.14K
May 16
Form 4
+12.92%
50K
$0.88
$44,000.00
437.14K
Feb 8
Form 4
+14.83%
50K
$1.71
$85,500.00
387.14K
Nov 29
Form 4
+6.31%
20K
$3.31
$66,200.00
337.14K
Sep 8
Form 4
+21.83%
56.82K
—
—
317.14K
Aug 31
Form 4
+8.32%
20K
$4.18
$83,600.00
260.33K
May 11
Form 4
+19.36%
38.99K
—
—
240.33K
Sep 1
Form 4
+14.18%
25K
$9.82
$245,500.00
201.34K
Sep 3
Form 4
+23.41%
33.45K
—
—
176.34K
Jul 19
Form 4
+21.21%
25K
$7.32
$183,000.00
142.9K
May 8
Form 4
+26.91%
25K
$8.93
$223,250.00
117.89K
Feb 12
Form 4
+36.82%
25K
$5.10
$127,500.00
92.89K
Dec 13
Form 4
+58.28%
25K
$5.34
$133,500.00
67.89K
Aug 31
Form 4
+60.66%
16.2K
—
—
42.9K
Jul 20
Form 4
+1,470.59%
25K
$15.13
$378,250.00
26.7K
May 11
Form 3
—
0
—
—
0
No matching records found